1. Home
  2. MHO vs BLLN Comparison

MHO vs BLLN Comparison

Compare MHO & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

HOLD

Current Price

$126.37

Market Cap

3.3B

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$79.45

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MHO
BLLN
Founded
1976
2016
Country
United States
United States
Employees
N/A
713
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MHO
BLLN
Price
$126.37
$79.45
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$160.00
$126.71
AVG Volume (30 Days)
178.6K
317.9K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
14.74
N/A
Revenue
$4,417,781,000.00
N/A
Revenue This Year
$0.66
$45.96
Revenue Next Year
$6.97
$30.11
P/E Ratio
$8.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$102.44
$61.96
52 Week High
$158.92
$138.70

Technical Indicators

Market Signals
Indicator
MHO
BLLN
Relative Strength Index (RSI) 51.72 50.53
Support Level $125.38 $64.99
Resistance Level $127.81 $83.20
Average True Range (ATR) 3.66 6.88
MACD 0.75 -0.07
Stochastic Oscillator 86.73 46.34

Price Performance

Historical Comparison
MHO
BLLN

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: